The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Open accessAbstract
Advanced glycation end products (AGEs) include a variety of protein adducts whose accumulation alters the structure and function of tissue proteins and stimulates cellular responses. They have been implicated in tissue damage associated with diabetic complications. To assess the possible link between AGE accumulation and the development of diabetic nephropathy (DN), we have examined the immunohistochemical localization of various AGE structures postulated to date, i.e., pentosidine, Nepsilon-(carboxymethyl)lysine (CML), and pyrraline, in diabetic and control kidneys. CML and pentosidine accumulate in the expanded mesangial matrix and thickened glomerular capillary walls of early DN and in nodular lesions and arterial walls of advanced DN, but were absent in control kidneys. By contrast, pyrraline was not found within diabetic glomeruli but was detected in the interstitial connective tissue of both normal and diabetic kidneys. Although the distribution of pyrraline was topographically identical to type III collagen, distribution of pentosidine and CML was not specific for collagen type, suggesting that difference in matrix protein composition per se could not explain heterogeneous AGE localization. Since oxidation is linked closely to the formation of pentosidine and CML, we also immunostained malondialdehyde (MDA), a lipid peroxidation product whose formation is accelerated by oxidative stress, assuming that local oxidative stress may serve as a mechanism of pentosidine and CML accumulation. Consistent with our assumption, diabetic nodular lesions were stained positive for MDA. These findings show that AGE localization in DN varies according to AGE structure, and suggest that the colocalization of markers of glycoxidation (pentosidine and CML) with a marker of lipid peroxidation reflects a local oxidative stress in association with the pathogenesis of diabetic glomerular lesions. Thus, glycoxidation markers may serve as useful biomarkers of oxidative damage in DN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Excessive AGE formation is particularly associated with cross-linking of matrix proteins such as collagen, vitronectin, and laminin.[2,10,11]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [2]
In the citing paper
“The rate of AGE formation in the body is greatly enhanced in diabetes.[2,3]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,791
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,512
Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,545
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y., Pinsky, D. J., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,305
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,272
Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix
Sell, D. R., & Monnier, V. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88225-8 · Cited by 1,082
Self-citationAhmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed · Cited by 780
Hunt, J. V., Dean, R. T., & Wolff, S. P. (1988) · Biochemical Journal · doi:10.1042/bj2560205 · Cited by 779
Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
Dyer, D. G., Dunn, J. A., Thorpe, S. R., Bailie, K., Lyons, T. J., McCance, D. R., & Baynes, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116481 · Cited by 770
Cited by
Sorted by citations
Items 301–400 of 433
Glycation and Glycoxidation in Diabetic Vascular Disease
Thorpe, S. R., Lyons, T. J., & Baynes, J. (2000) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-4649-8_14 · Cited by 15
Matsumoto, T., Ozawa, Y., Taguchi, K., Kobayashi, T., & Kamata, K. (2009) · Peptides · doi:10.1016/j.peptides.2009.11.029 · Cited by 15
Miyamura, M., Schnell, O., Yamashita, C., Yoshioka, T., Matsumoto, C., Mori, T., Ukimura, A., Kitaura, Y., Matsumura, Y., Ishizaka, N., et al. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10014fp · Cited by 15
Aso, Y., Takanashi, K., Sekine, K., Yoshida, N., Takebayashi, K., Yoshihara, K., & Inukai, T. (2004) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2004.03.016 · Cited by 15
Pathogenesis of Microvascular Complications
Giacco, F., & Brownlee, M. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch35 · Cited by 15
MECHANISM OF DIABETIC NEPHROPATHY: ROLE OF PROTEIN KINASE-C ACTIVATION —
Ohshiro, Y., Lee, Y., & King, G. L. (2005) · Cited by 14
Himeno, T., Kamiya, H., Naruse, K., Cheng, Z., Ito, S., Shibata, T., Kondo, M., Kato, J., Okawa, T., Fujiya, A., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2015/257230 · Cited by 13
Reversal of hypertriglyceridemia in diabetic BTBR ob/ob mice does not prevent nephropathy
Attie, A., Schueler, K., Keller, M. P., Mitok, K. A., Simonett, S. P., Hudkins, K. L., Mehrotra, K., Graham, M. J., Lee, R. G., & Alpers, C. E. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00592-8 · Cited by 14
“recognized by the E06 antibody can be detected in kidneys from diabetic subjects [35].”
BackgroundGlycoxidative modification of AA amyloid deposits in renal tissue
Uesugi, N., Sakata, N., Nagai, R., Jono, T., Horiuchi, S., & Takebayashi, S. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.3.355 · Cited by 14
Hara, S., Umeyama, K., Yokoo, T., Nagashima, H., & Nagata, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092219 · Cited by 13
“Specifically, CML is the major AGE accumulated in nodular lesions [20,21].”
Wada, J., & Makino, H. (2009) · Clinical and Experimental Nephrology · doi:10.1007/s10157-009-0175-5 · Cited by 13
“Makita et al. [35], Makino et al. [36], and Horie et al. [ 37 ] reported the presence of AGEs in the mesangial area of diabetic nephropathy patients.”
BackgroundAcute Insulin Resistance Mediated by Advanced Glycation Endproducts in Severely Burned Rats
Zhang, X., Xu, J., Cai, X., Ji, L., Li, J., Cao, B., Li, J., Hu, D., Li, Y., Wang, H., et al. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000314 · Cited by 13
“Carboxymethyllysine (CML) is a principal AGE that accumulates in vivo (15, 16).”
BackgroundLipopolysaccharide-induced VEGF production and ambient oxidative stress in type 2 diabetes
Earle, K., Zitouni, K., & Nourooz‐Zadeh, J. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00836 · Cited by 13
Exercise and oxidative stress in diabetes mellitus
Laaksonen, D. E., & Sen, C. K. (2000) · Elsevier eBooks · doi:10.1016/b978-044482650-3/50038-9 · Cited by 13
Oxidants and Iron in Progressive Kidney Disease
Shah, S. V. (2006) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.04.009 · Cited by 13
Jamuna, J. B., & Nandini, C. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.12.003 · Cited by 12
“The resultant enhancement in glucose metabolic flux leads to activation of a number of metabolic pathways that result in increased advanced glycation end products (AGEs) and oxidative stress generation [2].”
BackgroundOhtomo, S., Izuhara, Y., Nangaku, M., Dan, T., Ito, S., de Strihou, C. V. Y., & Miyata, T. (2010) · Journal of Obesity · doi:10.1155/2010/136502 · Cited by 12
Self-citationWang, H., Zhang, H., CHEN, X., Zhao, T., Kong, Q. Q., Yan, M., Zhang, B., Sun, S., LAN, H.-Y., Li, N., et al. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2533 · Cited by 12
“suggested to be a common mediator in apoptosis (30,31) and particularly in DN, a state in which oxidative stress is increased by high glucose and dyslipidemia (32).”
Fatima, N., Khan, M., Jawed, H. A., Qureshi, U., Ul‐Haq, Z., Hafizur, R. M., Shah, T. A., Dauelbait, M., Jardan, Y. A. B., & Shazly, G. A. (2024) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-024-00811-0 · Cited by 11
Katakami, N., Kume, S., Kaneto, H., Uzu, T., Kashiwagi, A., Yamasaki, Y., Maegawa, H., & Shimomura, I. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0345 · Cited by 11
LIANG, W., Luo, Q., ZHANG, Z., YANG, K., YANG, A., Chi, Q., & HU, H. (2022) · Biocell · doi:10.32604/biocell.2022.019300 · Cited by 11
Methylglyoxal induces prostaglandin E2 production in rat mesangial cells.
Uriuhara, A., Miyata, S., Liu, B.-F., Miyazaki, H., Kusunoki, H., Kojima, H., Yamashita, Y., Suzuki, K., Inaba, K., & Kasuga, M. (2008) · PubMed · doi:10.24546/81000130 · Cited by 11
Self-citationZinc Chloride Protects against Streptozotocin-Induced Diabetic Nephropathy in Rats
Almalki, W. H., Arafa, E. A., Abdallah, A. Y., Mahfoz, A. M., Osman, A. O., El‐Latif, H. A. A., & Shahid, I. (2016) · Pharmacology & Pharmacy · doi:10.4236/pp.2016.78041 · Cited by 11
Identification of AGE-modified proteins in SH-SY5Y and OLN-93 Cells
Langer, A. K., Poon, H. F., Münch, G. W., Lynn, B. C., Arendt, T., & Butterfield, D. A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033316 · Cited by 11
“Some of the resultant adducts are protein-protein-crosslinks including pentosidine, methylglyoxal lysine dimer (MOLD), glyoxal lysine dimer (GOLD) or vesperlysine (Horie et al., 1997; Miyata et al., 1998; Nakamura et al., 1997; Münch et al., 1999).”
BackgroundZhang, H., Zhang, S., Wang, L., Liu, X., & Wu, Y. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.12.032 · Cited by 11
Editorial: Diet, Inflammation, and Chronic Kidney Disease: Getting to the Heart of the Matter
Neade, T., & Uribarri, J. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00445.x · Cited by 11
Yang, C., Bao, L., Shi, Z., Xv, X., Jiang, D., & You, L. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae028 · Cited by 10
Immune Modulation by Myeloid-Derived Suppressor Cells in Diabetic Kidney Disease
Hsieh, C., Chang, C., Hsu, Y., & Lin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113263 · Cited by 10
Hintzpeter, J., Martin, H., & Maser, E. (2014) · The FASEB Journal · doi:10.1096/fj.14-258327 · Cited by 10
Buongiorno, A. M., Morelli, S., Sagratella, E., Cipriani, R., Mazzaferro, S., Morano, S., & Sensi, M. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346408 · Cited by 10
Tomé, C. C., Silva, M. V. D. R., Rodríguez, J., Rodríguez‐Segade, S., & Sánchez‐Salorio, M. (2005) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-004-1108-3 · Cited by 10
“xidation in vivo [8], were measured and compared.”
MethodFrom Molecular Footprints of Disease to New Therapeutic Interventions in Diabetic Nephropathy
Miyata, T., YAMAMOTO, M., & Izuhara, Y. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.086 · Cited by 10
Self-citationOrganelle stress and glycation in kidney disease
Inagi, R. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-09989-5 · Cited by 9
Role of Advanced Glycation End Products in the Progression of Diabetes Mellitus
Xu, Y., & Guo, H. (2017) · Global Journal of Obesity Diabetes and Metabolic Syndrome · doi:10.17352/2455-8583.000019 · Cited by 9
Association of lipid abnormalities and oxidative stress with diabetic nephropathy
Kachhawa, K., Agrawal, D., Rath, B., & Kumar, S. (2017) · Journal of integrative nephrology and andrology · doi:10.4103/jina.jina_1_17 · Cited by 9
Oxidative Stress and Hypoxia in the Pathogenesis of Diabetic Nephropathy
Palm, F., Nordquist, L., Wilcox, C. S., & Hansell, P. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_29 · Cited by 9
Pathophysiology of Diabetic Nephropathy
Khoury, C. C., Chen, S., & Ziyadeh, F. N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00013-5 · Cited by 9
Kamata, K., Ozawa, Y., Kobayashi, T., & Matsumoto, T. (2009) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.45.125 · Cited by 8
Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin–Angiotensin System Blockade
Jin, S., Han, K. A., Yu, J. M., Sohn, T. S., Choi, S. H., Chung, C. H., Park, I. B., Rhee, E., Baik, S. H., Park, T. S., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308034 · Cited by 8
MlYATA, T., & Kurokawa, K. (2003) · Internal Medicine · doi:10.2169/internalmedicine.42.1165 · Cited by 8
Self-citationZhuang, A., Yap, F. Y. T., Borg, D. J., McCarthy, D. A., Fotheringham, A. K., Leung, S. S., Penfold, S. A., Sourris, K. C., Coughlan, M. T., Schulz, B. L., et al. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.278 · Cited by 7
Maier, H. M., Ilich, J. Z., Kim, J., Levenson, C. W., Arjmandi, B. H., & Spicer, M. T. (2014) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-3-2 · Cited by 7
“AGE are elevated in retinal vessels of Streptozotocin (STZ) induced diabetic rats [11] and in the renal glomeruli of patients with diabetic nephropathy [12].”
BackgroundOxidative and Glycooxidative Stress in Diabetic Nephropathy
DeRubertis, F. R., & Cravens, P. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-153-6_9 · Cited by 7
Pentosidine and Its Deposition in Renal Tissue in Renal Transplantation
Yoshida, K., Yoneda, T., Fujimoto, K., Hirao, Y., & Konishi, N. (2005) · Transplantation Proceedings · doi:10.1016/j.transproceed.2005.11.018 · Cited by 7
Pathogenesis of Diabetic Microvascular Complications
He, Z., Rask‐Madsen, C., & King, G. L. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0901 · Cited by 7
Antioxidant status in J774A.1 macrophage cell line during chronic exposure to glycated serum
Bassi, A. M., Ledda, S., Pascale, M. C. D., Penco, S., Rossi, S., Odetti, P. R., & Cottalasso, D. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-024 · Cited by 7
Miyataka, K., Kaneko, Y., Hori, T., Yamaguchi, Y., Tsuji, S., Hara, T., Yamagami, H., Yoshida, S., Otoda, T., Yuasa, T., et al. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70149 · Cited by 8
“40 have reported that pentosidine was detected immunohis-tochemically in both the glomeruli and tubules of type 2 diabetes subjects with overt albuminuria, whereas in type 2 diabetes subjects without overt albuminuria, pentosidine was detected in the tubules but not in the glomeruli.”
Wagner, Z., Degrell, P., Lukáts, B., Niwa, T., Molnár, G. A., Markó, L., Karádi, Z., & Wittmann, I. (2011) · Journal of Nephrology · doi:10.5301/jn.2011.6520 · Cited by 6
Ibrahim, A. A.-S., Morsy, M. M., Abouhashem, S. E., Aly, O., Sabbah, N. A., & Raafat, N. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00064-6 · Cited by 6
Simplified System to Investigate Alteration of Retinal Neurons in Diabetes
Dong, S., Liu, Y., Zhu, M., Xu, X., & Le, Y.-Z. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_18 · Cited by 6
Characterization of antibody affinities using an AGE-modified dipeptide spot library
Dukić-Stefanović, S., Schicktanz, D., Wong, A. O., Palm, D., Riederer, P. F., Niwa, T., Schinzel, R., & Münch, G. W. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00097-2 · Cited by 6
Diabetic nephropathy: Pathophysiology and potential therapeutic role of plant extracts
Mir, M. N., Malik, I. A., Naik, R. A., Singh, S., Hurra, A. R., Wani, Z., Shah, R., & Lone, Y. (2025) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2025.100263 · Cited by 5
Carboxymethyl-lysine is a Prominent Target of Circulating IgA in IgA Nephropathy
Alibrandi, S., Aguiar, T. F. M., Ausmeier, M., Molinari, P., Fiaccadori, E., Maggiore, U., Chun, N. H., Lanau, M., Arnedo, M. P., Manrique, J., et al. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.04.016 · Cited by 6
“19 In DN, AGE can be detected virtually in all renal structures and cells, including the basement membrane, mesangium, endothelial cells, podocytes, and tubules, 20 mostly due to accelerated oxidative stress and delayed protein turn-over.”
Mbatha, B., Khathi, A., Sibiya, N. H., Booysen, I. N., Mangundu, P., & Ngubane, P. S. (2021) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0278 · Cited by 5
Pathogenesis of renal microvascular complications in diabetes mellitus.
Veldman, B. A. J., & Vervoort, G. (2002) · PubMed · Cited by 5
Jung, Y. S., & Shin, H. (2016) · 대한한의학회지 · doi:10.13048/jkm.16022 · Cited by 5
Williams, M. E., & Stanton, R. C. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00003-0 · Cited by 5
Vasantha, G., Dayakar, C., Vasudha, D., Tejolahari, I., & Chandrika, S. B. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00019 · Cited by 4
Rasal, P. B., Kasar, G. N., Mahajan, M., Upaganlawar, A. B., & Upasani, C. D. (2023) · International Journal of Plant Based Pharmaceuticals · doi:10.29228/ijpbp.24 · Cited by 4
“The hallmarks of DN comprise buildup of extracellular matrix, stiffness of the basal membrane, scarring of the glomerulus, podocyte mislaid, enlargement of mesangial cells, and tubular abnormalities (Arora & Singh, 2013; Horie et al., 1997; Ritz, 2013).”
Xiao, W., Han, X., Tan, Z., Tang, S. X., Gong, Z., Bamikole, M. A., & Ren, G. P. (2010) · Journal of Food Science and Technology · doi:10.1007/s13197-010-0192-0 · Cited by 4
“MDA is an end product of lipid peroxidation whose formation is accelerated by oxidative stress ( Horie et al 1997 ) and thus detection of MDA can reflect the level of oxygen free radicals and the extent of lipid peroxidation.”
BackgroundMansouri, E. (2012) · Asian Biomedicine · doi:10.5372/1905-7415.0602.046 · Cited by 4
“In addition, antioxidant has been suggested to have potentially helpful effects in the human kidney and experimental diabetes [4, 5].”
BackgroundCha, S., Han, E. J., Ahn, G., & Jun, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8023-5_44 · Cited by 4
Biochemistry and Molecular Biology of Diabetic Complications
Sakamoto, K., & Brownlee, M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-310-1_21 · Cited by 5
Serum Levels of Nε-(Carboxymethyl)-Lysine in Chronic Kidney Disease and Type 2 Diabetes Mellitus
Tsekovska, R., Gatev, E., Mironova, R., Kerezieva, S., Ilieva, S., Ilieva, T., Vasileva, B., Niwa, T., Popova, D., & Vasilev, V. V. (2025) · Biomedicines · doi:10.3390/biomedicines13071672 · Cited by 3
“…should be considered that in contrast to free CML in blood, CML bound to tissue proteins becomes immunogenic, and that in non-diabetics with CKD, CML accumulates mainly in the renal tissue, while in diabetics, many other tissues can be affected as a result of enhanced glycoxidative stress [66,67].”
Pandey, A. K., Badruddeen, B., Akhtar, J., Khan, M. I., Ahmad, M., & Islam, A. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113211 · Cited by 4
Yáñez, A. J., Jaramillo, K., Blaña, C., Burgos, R. A., Isla, A., Silva, P., & Aguilar, M. N. (2023) · Biomedicines · doi:10.3390/biomedicines11020417 · Cited by 3
Yamagami, H., Hara, T., Yasui, S., Hosoki, M., Hori, T., Kaneko, Y., Mitsui, Y., Kurahashi, K., Harada, T., Yoshida, S., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11113020 · Cited by 3
Recruiting a transcription factor in the liver to prevent atherosclerosis
Attie, A. D. (2021) · Journal of Clinical Investigation · doi:10.1172/jci154677 · Cited by 3
Additive effects of dietary glycotoxins and androgen excess on the kidney of a female rat model
Palimeri, S., Palioura, E., Piperi, C., Kandaraki, E., Sergentanis, T. Ν., Levidou, G., Papalois, A. E., Korkolopoulou, P. A., Papavassiliou, A. G., & Diamanti‐Kandarakis, E. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2015.07.002 · Cited by 3
“The present data are in agreement with previous studies suggesting that almost all renal structures are susceptible to the accumulation of AGEs including basement membranes, mesangial and endothelial cells, podocytes and tubules.(35,36) Vlassara et al.”
ResultHuman HO-1 Deficiency and Cardiovascular Dysfunction
Yachie, A., Kawashima, A., Ohta, K., Saikawa, Y., & Koizumi, S. (2001) · CRC Press eBooks · doi:10.1201/9781420041019.ch11 · Cited by 3
Gu, Y., Wang, Y., Zhang, H., Zhao, T., Sun, S., Wang, H., Zhu, B., & Li, P. (2017) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600123 · Cited by 3
Advanced Glycation End Products
Biruete, A., & Uribarri, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-44858-5_29 · Cited by 3
Mechanisms of Diabetic Nephropathy in Humans and Experimental Animals
Khoury, C. C., Chen, S., & Ziyadeh, F. N. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_9 · Cited by 2
Mitochondrial dysfunction and diabetes in South Africa: A review
Pearce, B., & Pearce, K. M. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100157 · Cited by 2
de Haan, J. B., Jandeleit-Dahm, K. A. M., & Allen, T. J. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-956-7_1 · Cited by 2
Advanced Glycation End Products Inhibitor
Dan, T., de Strihou, C. V. Y., & Miyata, T. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_20 · Cited by 2
“Oxidative stress contributes to AGE formation as shown by the correlation observed in diabetic and uremic serum between pentosidine (an AGE) and oxidative markers such as dehydroascorbate and advanced oxidation protein products (AOPP) [21, 22] as well as by the colocalization of both oxidation-dependent AGE structures…”
BackgroundSelf-citationAdvanced Glycation and Advanced Oxidation Protein Products: The Effect of Peritoneal Dialysis
de Strihou, C. V. Y., & Miyata, T. (2006) · Peritoneal Dialysis International · doi:10.1177/089686080602600211 · Cited by 2
Self-citationKang, K. S., Yamabe, N., Kim, H., & Yokozawa, T. (2010) · doi:10.11339/jtm.27.97 · Cited by 2
Fujimoto, N., & Tajima, S. (2004) · British Journal of Dermatology · doi:10.1111/j.0007-0963.2004.05864.x · Cited by 2
Role of Antioxidant on Nephropathy in Alloxan Induced Diabetes in Rabbits
Al-Samaraee, I. F. J., & Jasim, H. A. (2009) · Iraqi postgraduate Medical Journal · Cited by 2
Agrawal, N. K., Singh, S. K., Singh, N., Kalra, S., & Srivastava, G. (2009) · The Internet Journal of Geriatrics and Gerontology · Cited by 2
Dai, T., Natarajan, R. D., Nast, C. C., LaPage, J. A., Chuang, P. Y., Sim, J. J., Tong, L., Chamberlin, M. P., Wang, S., & Adler, S. G. (2006) · Kidney International · doi:10.1038/sj.ki.5000200 · Cited by 2
Güleroğlu, F. Y., Bafalı, İ. O., Topaktas, M., Atalmış, H. A., Doğu, S. Y., Atas, B. S., Anayurt, E. Ö., Okyay, T. M., & Çetin, A. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01072-5 · Cited by 2
The kidney in different stages of the cardiovascular continuum
Nerpin, E. (2013) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2
High Glucose-induced ROS Production is Mediated by c-Src in Mesangial Cells
Lee, K. W. K. (2012) · TSpace (University of Toronto) · Cited by 2
Receptor for advanced glycation end-product in ischemia-reperfusion injury
Luo, X., Hu, Q., Ye, Q., & Zhong, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115792 · Cited by 1
Bhuvana, K., Revathy Praba, L., Jeevanandam, J., Esackimuthu, P., Raghavendran, S., & Saraswathi, N. T. (2025) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2025.101061 · Cited by 1
Zhou, Q., Yasumoto, Y., Masatoshi, T., Nozaki, T., Atsushi, S., Harada, K., Zhang, Y.-X., Lin, X., Yang-de, Z., & Arima, T. (2005) · Journal of Central South University of Technology · doi:10.1007/s11771-005-0430-1 · Cited by 1
Pentosidine: Can Be Related To The Etiology Of Chronic Kidney Disease?
Kerkeni, M., Bouzidi, H., Ahmed, L., & Hammami, M. (2014) · International Journal of Diabetology & Vascular Disease Research · doi:10.19070/2328-353x-140009 · Cited by 1
OXIDATIVE STRESS CONTRIBUTIONS TO CHRONIC COMPLICATIONS IN DIABETES
Savu, O., Ionescu-Tirgoviste, C., & Paulescu, N. (2008) · Cited by 1
Nitric Oxide/Peroxynitrite Balance in Kidney – Effect of Diabetes and Obesity
Huang, X. (2008) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Renal Microvascular Injury in Diabetes: RAGE and Redox Signaling
Coughlan, M. T., Cooper, M. E., & Forbes, J. M. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.ft-18 · Cited by 1
Rahim, M. Z. M., Azman, W. N. W., Yaacob, N. M., Mohamed, W. M. I. W., & Shafii, N. (2023) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.19.4.40 · Cited by 1
Unifying Hypothesis of Diabetic Complications
Matsumura, T., & Brownlee, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-572-5_12 · Cited by 1
Reddy, N. V. L. S., V, Raju, M. G., Alekhya, B., & Subrahmanyam, C. V. S. (2019) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2019.110103 · Cited by 1
Morcos, M., & Nawroth, P. (1999) · Springer eBooks · doi:10.1007/978-3-642-58588-3_11 · Cited by 1
Beraiya, S., Ishfaq, P. M., Ahmad, Z., TRIPATHI, S., & Mishra, S. K. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2019.v12i10.34886 · Cited by 1
Oxidant stress is increased within the glomerulus in experimental diabetic nephropathy
Kitching, A. R., Rüger, B. M., & Davis, P. F. (2000) · Nephrology · doi:10.1046/j.1440-1797.2000.00011.x · Cited by 1
“In several models of inflammatory renal injury an important role for ROS and lipid peroxides has been demonstrated(14,15,22) and a recent human study demonstrated the presence of lipid peroxides (MDA) in glomeruli of humans with diabetic nephropathy.(9) The current study sought to address the hypothesis that oxidant s…”
BackgroundAre prognostic factors in rheumatoid arthritis of any use in daily clinical practice?
van Riel, P. L. C. M. (2002) · PubMed · Cited by 1
Oxidants in Progressive Kidney Disease
Shah, S. V. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50095-4 · Cited by 1
Metadata
- Authors
- Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., & Kurokawa, K.
- Affiliations
- Nagoya University (JP)
- Tokai University (JP)
- Kobe University (JP)
- Chukyo Hospital (JP)
- Case Western Reserve University (US)
- University of California San Diego (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1997-12-15
- Volume
- 100
- Issue
- 12
- Pages
- 2995-3004
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508511
- OpenAlex
- W2085341182
- Cited by
- 433
- References
- 56
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 7 · 2022: 9 · 2021: 14 · 2020: 10 · 2019: 10 · 2018: 7 · 2017: 12 · 2016: 10 · 2015: 8 · 2014: 14 · 2013: 9 · 2012: 15
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion, other-oa)
- Funders
- Japan Society for the Promotion of Science (96L00303)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- advanced glycation end products, glycoxidation, lipid peroxidation, diabetic nephropathy, pentosidine, carboxymethyllysine, pyrraline, malondialdehyde, oxidative stress, glomerular lesions, mesangial matrix, type III collagen, oxidative damage biomarkers
- MeSH terms
- Adolescent, Adult, Aged, Animals, Antibodies, Arginine, Collagen, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Female, Humans, Immunoenzyme Techniques, Kidney Glomerulus, Lysine, Male, Malondialdehyde, Middle Aged, Nephrotic Syndrome, Norleucine, Pyrroles, Rabbits, Lipid Peroxidation, Glycation End Products, Advanced, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review